تداخل‌های دارویی
Deferiprone + Trastuzumab deruxtecan
شدت: شدید
Deferiprone and Trastuzumab deruxtecan: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Deferiprone can cause neutropenia and agranulocytosis, and trastuzumab deruxtecan is also associated with neutropenia. Used together, the risk of severe myelosuppression and serious infection is higher.
معنای این تداخل به زبان ساده
Deferiprone and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferiprone belongs to Miscellaneous; Trastuzumab deruxtecan belongs to Oncology.
چرا رخ می‌دهد
Additive pharmacodynamic myelosuppression affecting neutrophil counts.
اقدام لازم
Avoid the combination where an alternative exists. If both are needed, check absolute neutrophil count more often than usual and interrupt deferiprone if neutropenia develops.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Deferiprone و Trastuzumab deruxtecan، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Deferiprone
تداخلات دیگر Trastuzumab deruxtecan
پرسش‌های متداول
Can I take Deferiprone with Trastuzumab deruxtecan?
MediHelp rates the interaction as major. Deferiprone and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferiprone can cause neutropenia and agranulocytosis, and trastuzumab deruxtecan is also associated with neutropenia. Used together, the risk of severe myelosuppression and serious infection is higher.
How serious is the interaction between Deferiprone and Trastuzumab deruxtecan?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where an alternative exists. If both are needed, check absolute neutrophil count more often than usual and interrupt deferiprone if neutropenia develops.
What other medicines interact with Deferiprone?
MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
